SAN FRANCISCO (PRWEB)
April 19, 2023
An industry first, Done. has reimagined today’s mental-health solutions with a revolutionary hybrid platform designed to tackle psychiatric care. Through an innovative and holistic approach, Done. now allows anyone to tap into the best of both virtual and in-person treatments to better help patients and clinicians achieve better clinical outcomes.
The new platform combines 200+ in-person offices through a blended use of trusted clinical partnerships and virtual care. As a result, Done. now meets patients whenever and wherever they are to deliver world-class psychiatric care nationwide. Hybrid care is defined as a combination of in-person with virtual coverage to provide a holistic option for the patient and provider to achieve the greatest clinical outcomes possible. Done. achieves this fusion of coverage through a “direct” and collaborative care model. It merges Done.’s ongoing virtual care experience with high-touch in-person care conducted by Done.’s clinician consultations at Done. offices, through partner clinician in-person consultations, and via trusted provider referrals to distribute access to the best psychiatric care available.
Done’s mission has always been to empower and support our members in reaching their potential. We started Done because there was a lack of qualified clinicians to treat patients and because patients struggled to access care within their communities. As the Biden administration announced on January 30, 2023, the COVID-19 public-health emergency (PHE) will end on May 11, 2023.
Based on the updated regulation, the Done. team has now adapted to meet the needs of how society has shifted by providing a combination of in-person and virtual care. In 2020, given the velocity of patient demand as well as the need to accommodate regulations for virtual care licensing and prescribing, the physical and economic barriers to access, particularly in underserved communities, were eliminated. Now, post-pandemic, and given our original mission to meet patients when and where they are, we are doing just that – offering the best in both in-person and virtual care through Done. offices and partnerships to serve patients with holistic psychiatric care that goes beyond ADHD treatment. As the means to distribute care shifts, so, too, is the nature of the treatment. Done. first committed to better access and efficiency for ADHD care.
Today, we’ve built a technology platform that sets a higher standard for patient care, and while we believe that our specialization in ADHD allows us to achieve better clinical outcomes and safer patient care, we are now ready to expand into a holistic approach that focuses on a wider range of psychiatric challenges.
Working in tandem with in-person medical practitioners, the Done. platform arms clinicians with deeper data and insights to ensure accurate diagnoses and allow monitoring of patient use of prescribed drugs to ensure proper dosage and mitigate potential abuse. The Done. platform leads the way to encapsulate how technology can improve the quality and effectiveness of healthcare services to make life better for patients.
As Done. scales our hybrid model nationally to all members, we are taking all necessary precautions to ensure a smooth transition for our patients and will keep them informed throughout the process. To learn more about the platform, visit DoneFirst.com.
About Done.
Done. is a hybrid-care (in-person + virtual) health platform that empowers anyone living with mental health challenges to reach their fullest potential. Through a patient-first, technology-powered platform, industry-leading digital-health company, Done. makes high-quality psychiatric chronic care management more accessible and affordable. Disclaimer: Done. is an online platform that connects members with qualified clinicians to screen, diagnose, and treat members with ADHD. Done. does not provide medical services. All professional services on the Done. platform are provided by clinicians who are psychiatric board-certified medical professionals;
Done. does not engage in the prescription business.
Share article on social media or email: